57 related articles for article (PubMed ID: 20030653)
1. An exception to tumour neoangiogenesis in a malignant breast-lesion.
Baltzer PA; Benndorf M; Gajda M; Kaiser WA
Breast J; 2010; 16(2):197-8. PubMed ID: 20030653
[TBL] [Abstract][Full Text] [Related]
2. Ductal carcinoma in situ: is there a role for MRI?
Zuiani C; Francescutti GE; Londero V; Zunnui I; Bazzocchi M
J Exp Clin Cancer Res; 2002 Sep; 21(3 Suppl):89-95. PubMed ID: 12585661
[TBL] [Abstract][Full Text] [Related]
3. AG-013736, a novel inhibitor of VEGF receptor tyrosine kinases, inhibits breast cancer growth and decreases vascular permeability as detected by dynamic contrast-enhanced magnetic resonance imaging.
Wilmes LJ; Pallavicini MG; Fleming LM; Gibbs J; Wang D; Li KL; Partridge SC; Henry RG; Shalinsky DR; Hu-Lowe D; Park JW; McShane TM; Lu Y; Brasch RC; Hylton NM
Magn Reson Imaging; 2007 Apr; 25(3):319-27. PubMed ID: 17371720
[TBL] [Abstract][Full Text] [Related]
4. Maximum intensity projection analysis in magnetic resonance of the breast.
Carriero A; Di Credico A; Mansour M; Bonomo L
J Exp Clin Cancer Res; 2002 Sep; 21(3 Suppl):77-81. PubMed ID: 12585659
[TBL] [Abstract][Full Text] [Related]
5. Magnetic resonance of the breast: correlation between enhancement patterns and microvessel density in malignant tumors.
Carriero A; Ambrossini R; Mattei PA; Angelucci D; Bonomo L
J Exp Clin Cancer Res; 2002 Sep; 21(3 Suppl):83-7. PubMed ID: 12585660
[TBL] [Abstract][Full Text] [Related]
6. Magnetic resonance imaging of the breast improves detection of invasive cancer, preinvasive cancer, and premalignant lesions during surveillance of women at high risk for breast cancer.
Riedl CC; Ponhold L; Flöry D; Weber M; Kroiss R; Wagner T; Fuchsjäger M; Helbich TH
Clin Cancer Res; 2007 Oct; 13(20):6144-52. PubMed ID: 17947480
[TBL] [Abstract][Full Text] [Related]
7. Differentiation of benign and malignant sub-1 cm breast lesions using dynamic contrast enhanced MRI.
Gibbs P; Liney GP; Lowry M; Kneeshaw PJ; Turnbull LW
Breast; 2004 Apr; 13(2):115-21. PubMed ID: 15019691
[TBL] [Abstract][Full Text] [Related]
8. Ductal pattern enhancement on magnetic resonance imaging of the breast due to ductal lavage.
Ghanouni P; Kurian AW; Margolis D; Hartman AR; Mills MA; Plevritis SK; Ford JM; Daniel BL
Breast J; 2007; 13(3):281-6. PubMed ID: 17461903
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the three-time-point method for diagnosis of breast lesions in contrast-enhanced MR mammography.
Hauth EA; Stockamp C; Maderwald S; Mühler A; Kimmig R; Jaeger H; Barkhausen J; Forsting M
Clin Imaging; 2006; 30(3):160-5. PubMed ID: 16632149
[TBL] [Abstract][Full Text] [Related]
10. Magnetic resonance imaging measurements of vascular permeability and extracellular volume fraction of breast tumors by dynamic Gd-DTPA-enhanced relaxometry.
Vincensini D; Dedieu V; Eliat PA; Vincent C; Bailly C; de Certaines J; Joffre F
Magn Reson Imaging; 2007 Apr; 25(3):293-302. PubMed ID: 17371717
[TBL] [Abstract][Full Text] [Related]
11. Dynamic optical breast imaging: a novel technique to detect and characterize tumor vessels.
Fournier LS; Vanel D; Athanasiou A; Gatzemeier W; Masuykov IV; Padhani AR; Dromain C; Galetti K; Sigal R; Costa A; Balleyguier C
Eur J Radiol; 2009 Jan; 69(1):43-9. PubMed ID: 18829193
[TBL] [Abstract][Full Text] [Related]
12. MR mammography with pharmacokinetic mapping for monitoring of breast cancer treatment during neoadjuvant therapy.
Knopp MV; Brix G; Junkermann HJ; Sinn HP
Magn Reson Imaging Clin N Am; 1994 Nov; 2(4):633-58. PubMed ID: 7489314
[TBL] [Abstract][Full Text] [Related]
13. Rates of reexcision for breast cancer after magnetic resonance imaging-guided bracket wire localization.
Wallace AM; Daniel BL; Jeffrey SS; Birdwell RL; Nowels KW; Dirbas FM; Schraedley-Desmond P; Ikeda DM
J Am Coll Surg; 2005 Apr; 200(4):527-37. PubMed ID: 15804466
[TBL] [Abstract][Full Text] [Related]
14. Contrast kinetics of the malignant breast tumour--border versus centre enhancement on dynamic midfield MRI.
Marklund M; Torp-Pedersen S; Bentzon N; Thomsen C; Roslind A; Nolsøe CP
Eur J Radiol; 2008 Feb; 65(2):279-85. PubMed ID: 17467219
[TBL] [Abstract][Full Text] [Related]
15. Characterization of breast lesions with CE-MR multimodal morphological and kinetic analysis: comparison with conventional mammography and high-resolution ultrasound.
Vassiou K; Kanavou T; Vlychou M; Poultsidi A; Athanasiou E; Arvanitis DL; Fezoulidis IV
Eur J Radiol; 2009 Apr; 70(1):69-76. PubMed ID: 18295425
[TBL] [Abstract][Full Text] [Related]
16. BI-RADS MRI enhancement characteristics of ductal carcinoma in situ.
Rosen EL; Smith-Foley SA; DeMartini WB; Eby PR; Peacock S; Lehman CD
Breast J; 2007; 13(6):545-50. PubMed ID: 17983393
[TBL] [Abstract][Full Text] [Related]
17. Contrast-enhanced MR imaging of breast lesions and effect on treatment.
Schelfout K; Van Goethem M; Kersschot E; Colpaert C; Schelfhout AM; Leyman P; Verslegers I; Biltjes I; Van Den Haute J; Gillardin JP; Tjalma W; Van Der Auwera JC; Buytaert P; De Schepper A
Eur J Surg Oncol; 2004 Jun; 30(5):501-7. PubMed ID: 15135477
[TBL] [Abstract][Full Text] [Related]
18. [Fast MRI contrast medium dynamics for characterization of tumors. Experiences with functional MR-mammography].
Knopp MV; Hoffmann U; Brix G; Hawighorst H; Junkermann HJ; van Kaick G
Radiologe; 1995 Dec; 35(12):964-72. PubMed ID: 8584640
[TBL] [Abstract][Full Text] [Related]
19. Fusion of magnetic resonance and scintimammography images for breast cancer evaluation: a pilot study.
Duarte GM; Cabello C; Torresan RZ; Alvarenga M; Telles GH; Bianchessi ST; Caserta N; Segala SR; de Lima Mda C; Etchebehere EC; Camargo EE; Tinois E
Ann Surg Oncol; 2007 Oct; 14(10):2903-10. PubMed ID: 17632758
[TBL] [Abstract][Full Text] [Related]
20. Complementary role of adjunctive breast magnetic resonance imaging and scintimammography in patients of all ages undergoing breast cancer surgery.
Howarth D; Slater S; Lau P; Booker J; Clark D; Sillar R
Australas Radiol; 2005 Aug; 49(4):289-97. PubMed ID: 16026435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
